A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease

The CERAD behavior rating scale for dementia

Marian B. Patterson, James L. Mack, Joan A. Mackell, Ronald Thomas, Pierre Tariot, Myron Weiner, Peter J. Whitehouse

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

As part of the Alzheimer's Disease Cooperative Study (ADCS) Instrument Development Project, the CERAD Behavior Rating Scale for Dementia (BRSD) was examined for its sensitivity to degree of cognitive impairment, its test-retest reliability, and its sensitivity to longitudinal change. Sixty-four normal elderly participants and 261 patients with AD stratified into severity groups based on Mini-Mental State Exam (MMSE) scores were rated on the BRSD at baseline and 12-month followup visits. A subset of subjects was evaluated at a 1-month follow-up visit. Baseline BRSD Total Score discriminated the normal group from each AD group, and mean Total Score significantly increased with increasing dementia severity. Test-retest reliability between baseline and 1-month Total Scores was satisfactory for all AD groups. Longitudinal change was evaluated by 12-month change scores, which were significant in only the normal and in one AD group. From the results, we argue that the value of behavioral pathology assessment in clinical trials would be enhanced if additive scores were based on groups of correlated items rather than on a broad array of behaviors, some of which may increase and others may decrease in frequency as AD progresses.

Original languageEnglish (US)
JournalAlzheimer Disease and Associated Disorders
Volume11
Issue numberSUPPL. 2
StatePublished - 1997

Fingerprint

Longitudinal Studies
Dementia
Alzheimer Disease
Pathology
Reproducibility of Results
Clinical Trials
Behavior Rating Scale

Keywords

  • Alzheimer's disease cooperative study
  • Behavior rating scale for dementia
  • Longitudinal change
  • Test-retest reliability

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease : The CERAD behavior rating scale for dementia. / Patterson, Marian B.; Mack, James L.; Mackell, Joan A.; Thomas, Ronald; Tariot, Pierre; Weiner, Myron; Whitehouse, Peter J.

In: Alzheimer Disease and Associated Disorders, Vol. 11, No. SUPPL. 2, 1997.

Research output: Contribution to journalArticle

Patterson, Marian B. ; Mack, James L. ; Mackell, Joan A. ; Thomas, Ronald ; Tariot, Pierre ; Weiner, Myron ; Whitehouse, Peter J. / A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease : The CERAD behavior rating scale for dementia. In: Alzheimer Disease and Associated Disorders. 1997 ; Vol. 11, No. SUPPL. 2.
@article{c0b938af77714e28bab5e21688ba2859,
title = "A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: The CERAD behavior rating scale for dementia",
abstract = "As part of the Alzheimer's Disease Cooperative Study (ADCS) Instrument Development Project, the CERAD Behavior Rating Scale for Dementia (BRSD) was examined for its sensitivity to degree of cognitive impairment, its test-retest reliability, and its sensitivity to longitudinal change. Sixty-four normal elderly participants and 261 patients with AD stratified into severity groups based on Mini-Mental State Exam (MMSE) scores were rated on the BRSD at baseline and 12-month followup visits. A subset of subjects was evaluated at a 1-month follow-up visit. Baseline BRSD Total Score discriminated the normal group from each AD group, and mean Total Score significantly increased with increasing dementia severity. Test-retest reliability between baseline and 1-month Total Scores was satisfactory for all AD groups. Longitudinal change was evaluated by 12-month change scores, which were significant in only the normal and in one AD group. From the results, we argue that the value of behavioral pathology assessment in clinical trials would be enhanced if additive scores were based on groups of correlated items rather than on a broad array of behaviors, some of which may increase and others may decrease in frequency as AD progresses.",
keywords = "Alzheimer's disease cooperative study, Behavior rating scale for dementia, Longitudinal change, Test-retest reliability",
author = "Patterson, {Marian B.} and Mack, {James L.} and Mackell, {Joan A.} and Ronald Thomas and Pierre Tariot and Myron Weiner and Whitehouse, {Peter J.}",
year = "1997",
language = "English (US)",
volume = "11",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 2",

}

TY - JOUR

T1 - A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease

T2 - The CERAD behavior rating scale for dementia

AU - Patterson, Marian B.

AU - Mack, James L.

AU - Mackell, Joan A.

AU - Thomas, Ronald

AU - Tariot, Pierre

AU - Weiner, Myron

AU - Whitehouse, Peter J.

PY - 1997

Y1 - 1997

N2 - As part of the Alzheimer's Disease Cooperative Study (ADCS) Instrument Development Project, the CERAD Behavior Rating Scale for Dementia (BRSD) was examined for its sensitivity to degree of cognitive impairment, its test-retest reliability, and its sensitivity to longitudinal change. Sixty-four normal elderly participants and 261 patients with AD stratified into severity groups based on Mini-Mental State Exam (MMSE) scores were rated on the BRSD at baseline and 12-month followup visits. A subset of subjects was evaluated at a 1-month follow-up visit. Baseline BRSD Total Score discriminated the normal group from each AD group, and mean Total Score significantly increased with increasing dementia severity. Test-retest reliability between baseline and 1-month Total Scores was satisfactory for all AD groups. Longitudinal change was evaluated by 12-month change scores, which were significant in only the normal and in one AD group. From the results, we argue that the value of behavioral pathology assessment in clinical trials would be enhanced if additive scores were based on groups of correlated items rather than on a broad array of behaviors, some of which may increase and others may decrease in frequency as AD progresses.

AB - As part of the Alzheimer's Disease Cooperative Study (ADCS) Instrument Development Project, the CERAD Behavior Rating Scale for Dementia (BRSD) was examined for its sensitivity to degree of cognitive impairment, its test-retest reliability, and its sensitivity to longitudinal change. Sixty-four normal elderly participants and 261 patients with AD stratified into severity groups based on Mini-Mental State Exam (MMSE) scores were rated on the BRSD at baseline and 12-month followup visits. A subset of subjects was evaluated at a 1-month follow-up visit. Baseline BRSD Total Score discriminated the normal group from each AD group, and mean Total Score significantly increased with increasing dementia severity. Test-retest reliability between baseline and 1-month Total Scores was satisfactory for all AD groups. Longitudinal change was evaluated by 12-month change scores, which were significant in only the normal and in one AD group. From the results, we argue that the value of behavioral pathology assessment in clinical trials would be enhanced if additive scores were based on groups of correlated items rather than on a broad array of behaviors, some of which may increase and others may decrease in frequency as AD progresses.

KW - Alzheimer's disease cooperative study

KW - Behavior rating scale for dementia

KW - Longitudinal change

KW - Test-retest reliability

UR - http://www.scopus.com/inward/record.url?scp=0030754883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030754883&partnerID=8YFLogxK

M3 - Article

VL - 11

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

IS - SUPPL. 2

ER -